Related Experiment Video
Updated: Aug 13, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
The promyelocytic leukemia protein represses A20-mediated transcription
Wen-Shu Wu1, Zhi-Xiang Xu, Kun-Sang Chang
1Department of Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Abstract:
The promyelocytic leukemia (PML) protein is a tumor suppressor that is disrupted by the chromosomal translocation t(15;17), a consistent cytogenetic feature of acute promyelocytic leukemia. A role of PML in multiple pathways of apoptosis was conclusively demonstrated using PML(-/-) animal and cell culture models. In a previous study, we found that PML sensitizes tumor necrosis factor-induced apoptosis in tumor necrosis factor (TNF)-resistant U2OS cells. This finding helped to explain the mechanism of PML-induced apoptosis. The zinc finger protein A20 is a target gene of NF kappa B inducible by TNF alpha, and it is a potent inhibitor of TNF-induced apoptosis. In the this study, we demonstrated that PML is a transcriptional repressor of the A20 promoter and that PML represses A20 expression induced by TNF alpha. We showed that PML inhibits A20 transactivation through the NF kappa B site by interfering with its binding to the promoter. We also showed that stable overexpression of A20 inhibits apoptosis and caspase activation induced by PML/TNF alpha. The results of this study suggest that A20 is a downstream target of PML-induced apoptosis and supports a role of A20 in modulating cell death induced by PML/TNF alpha in TNF-resistant cells.
Insights
Promyelocytic leukemia (PML) protein represses A20 gene expression, a key inhibitor of apoptosis. This mechanism explains how PML sensitizes tumor cells to TNF-induced cell death, offering insights into cancer therapy.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Death Pathways
Background:
- The promyelocytic leukemia (PML) protein acts as a tumor suppressor and is implicated in apoptosis pathways.
- PML disruption via t(15;17) translocation is characteristic of acute promyelocytic leukemia.
- PML sensitizes TNF-resistant cells to apoptosis, suggesting a role in overcoming resistance.
Purpose of the Study:
- To investigate the mechanism by which PML sensitizes cells to TNF-induced apoptosis.
- To determine the relationship between PML and the A20 gene, an inhibitor of TNF-induced apoptosis.
- To elucidate the role of A20 as a downstream target in PML-mediated apoptosis.
Main Methods:
- Investigated PML's effect on the A20 promoter activity.
- Assessed PML's interference with NF-kappa B binding to the A20 promoter.
- Utilized cell culture models with stable A20 overexpression to study apoptosis and caspase activation.
Main Results:
- PML functions as a transcriptional repressor of the A20 promoter.
- PML inhibits TNF alpha-induced A20 expression by interfering with NF-kappa B binding.
- Overexpression of A20 confers resistance to apoptosis and caspase activation induced by PML/TNF alpha.
Conclusions:
- A20 is a downstream target of PML in the induction of apoptosis.
- PML-mediated repression of A20 is a critical mechanism for sensitizing TNF-resistant cells to apoptosis.
- This study provides a molecular basis for PML's role in modulating cell death in cancer.
More Related Videos
Related Concept Videos
RNA Polymerase II Accessory Proteins
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
Co-activators and Co-repressors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
Co-activators and Co-repressors

